Literature DB >> 16373054

[Breast metastases].

Dolores Arribas del Amo1, M Pilar Santero Ramírez, Elena Córdoba Díaz de Laspra, Fernando Martínez Ubieto, Mónica Corral Subías, Alfonso Cay Diarte.   

Abstract

Metastases in the breast resulting from extra-mammary tumours are infrequent, and the prognosis is poor. The main challenge in diagnosis is to differentiate between this condition and that of primary breast cancer so as to avoid unnecessary surgery. We present two cases that we encountered recently.

Entities:  

Mesh:

Year:  2005        PMID: 16373054     DOI: 10.1007/BF02716596

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  6 in total

Review 1.  Secondary neoplasms of the breast: a survey of the 20th Century.

Authors:  S N Georgiannos; J Chin; A W Goode; M Sheaff
Journal:  Cancer       Date:  2001-11-01       Impact factor: 6.860

2.  Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.

Authors:  J H Lagendijk; H Mullink; P J van Diest; G A Meijer; C J Meijer
Journal:  J Clin Pathol       Date:  1999-04       Impact factor: 3.411

3.  Clinical and ultrasonographic characteristics of breast metastases from extramammary malignancies.

Authors:  Chun-Nan Yeh; Cheng-Hung Lin; Miin-Fu Chen
Journal:  Am Surg       Date:  2004-04       Impact factor: 0.688

4.  Diagnosis and natural history of extramammary tumors metastatic to the breast.

Authors:  B Chaignaud; T J Hall; C Powers; C Subramony; C E Scott-Conner
Journal:  J Am Coll Surg       Date:  1994-07       Impact factor: 6.113

5.  Metastatic disease in the breast.

Authors:  M N Akçay
Journal:  Breast       Date:  2002-12       Impact factor: 4.380

6.  Metastases to the breast.

Authors:  I Alvarado Cabrero; M Carrera Alvarez; D Pérez Montiel; F A Tavassoli
Journal:  Eur J Surg Oncol       Date:  2003-12       Impact factor: 4.424

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.